Taysha Gene Therapies, Inc. (TSHA)
5.79
+0.03
(+0.52%)
USD |
NASDAQ |
Dec 12, 16:00
5.795
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Total Assets (Quarterly): 316.55M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AngioDynamics, Inc. | 265.64M |
| Anavex Life Sciences Corp. | 103.82M |
| Bolt Biotherapeutics, Inc. | 65.05M |
| Neurogene, Inc. | 287.83M |
| Aspire Biopharma Holdings, Inc. | 2.403M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 97.56M |
| Shareholders Equity (Quarterly) | 218.99M |
| Debt to Equity Ratio | 0.3174 |
| Current Ratio | 10.47 |
| Net Debt Paydown Yield | -0.26% |